Chapter 18: Introduction to Central Nervous System Pharmacology

Introduction to Central Nervous System Pharmacology on Central Nervous System (CNS) pharmacology explores how the brain and spinal cord manage complex physiological and behavioral responses through a sophisticated network of chemical messengers. Moving beyond historical "hard-wired" electrical models, the text details the modern "chemical milieu" model, where neurotransmitters and neuromodulators diffuse through the brain to influence distant neuronal clusters. The discussion centers on the lifecycle of these messengers, including their synthesis from amino acid precursors, vesicular storage, and calcium-dependent release into the synapse. It highlights how drug therapies typically address imbalances in these systems by either mimicking messengers or interfering with their termination via reuptake or enzymatic degradation. A major distinction is made between fast-acting ionotropic receptors, which provide immediate signaling for amino acids like GABA and glutamate, and slower metabotropic G protein-coupled receptors used by biogenic amines like serotonin and norepinephrine to modulate overall neuronal tone. The chapter categorizes essential messengers, from the primary inhibitory and excitatory amino acids to biogenic amines that regulate mood and motor coordination, and neuropeptides involved in pain processing. Furthermore, it explains the critical concepts of receptor regulation, where chronic pharmacological exposure leads to compensatory changes like down-regulation, which contributes to drug tolerance, or up-regulation following sustained antagonism. These principles are applied across six major functional domains: cognitive, emotional, memory, sensory, motor, and autonomic processing, providing a comprehensive framework for understanding how medications treat disorders ranging from Parkinson’s disease and schizophrenia to chronic pain and insomnia.